165 related articles for article (PubMed ID: 29650282)
21. Obstacles to precision oncology: confronting current factors affecting the successful introduction of biomarkers to the clinic.
Prudkin L; Nuciforo P
Cell Oncol (Dordr); 2015 Feb; 38(1):39-48. PubMed ID: 25185990
[TBL] [Abstract][Full Text] [Related]
22. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
Morgan G; Aftimos P; Awada A
Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
[TBL] [Abstract][Full Text] [Related]
23. The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells.
Soundararajan S; Chen W; Spicer EK; Courtenay-Luck N; Fernandes DJ
Cancer Res; 2008 Apr; 68(7):2358-65. PubMed ID: 18381443
[TBL] [Abstract][Full Text] [Related]
24. Lung cancer as a paradigm for precision oncology in solid tumours.
Schallenberg S; Merkelbach-Bruse S; Buettner R
Virchows Arch; 2017 Aug; 471(2):221-233. PubMed ID: 28730537
[TBL] [Abstract][Full Text] [Related]
25. New perspectives of physiological and pathological functions of nucleolin (NCL).
Jia W; Yao Z; Zhao J; Guan Q; Gao L
Life Sci; 2017 Oct; 186():1-10. PubMed ID: 28751161
[TBL] [Abstract][Full Text] [Related]
26. Management and Outcomes in Metaplastic Breast Cancer.
Tzanninis IG; Kotteas EA; Ntanasis-Stathopoulos I; Kontogianni P; Fotopoulos G
Clin Breast Cancer; 2016 Dec; 16(6):437-443. PubMed ID: 27431460
[TBL] [Abstract][Full Text] [Related]
27. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
28. Is precision medicine ready for use in breast cancer?
Pusztai L
Clin Adv Hematol Oncol; 2016 Dec; 14(12):964-966. PubMed ID: 28212357
[No Abstract] [Full Text] [Related]
29. Cancer prevention in the era of precision oncology.
Brahme NN; Szabo E
Clin Pharmacol Ther; 2017 May; 101(5):575-577. PubMed ID: 28032900
[TBL] [Abstract][Full Text] [Related]
30. Being more precise in assessing the value of precision medicine in breast cancer.
Curigliano G
Breast; 2016 Oct; 29():186-7. PubMed ID: 27600532
[No Abstract] [Full Text] [Related]
31. Combination therapy approaches to target insulin-like growth factor receptor signaling in breast cancer.
Ochnik AM; Baxter RC
Endocr Relat Cancer; 2016 Nov; 23(11):R513-R536. PubMed ID: 27733416
[TBL] [Abstract][Full Text] [Related]
32. Integrated patient and tumor genetic testing for individualized cancer therapy.
Hertz DL; McLeod HL
Clin Pharmacol Ther; 2016 Feb; 99(2):143-6. PubMed ID: 26537014
[TBL] [Abstract][Full Text] [Related]
33. Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy.
Jo SD; Ku SH; Won YY; Kim SH; Kwon IC
Theranostics; 2016; 6(9):1362-77. PubMed ID: 27375785
[TBL] [Abstract][Full Text] [Related]
34. Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.
Stover DG; Wagle N
Curr Oncol Rep; 2015 Apr; 17(4):15. PubMed ID: 25708799
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer subtypes: morphologic and biologic characterization.
Masood S
Womens Health (Lond); 2016 Jan; 12(1):103-19. PubMed ID: 26756229
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine.
Smith B; Agarwal P; Bhowmick NA
Endocr Relat Cancer; 2017 May; 24(5):R157-R172. PubMed ID: 28289080
[TBL] [Abstract][Full Text] [Related]
37. Targeting Stemness: Implications for Precision Medicine in Breast Cancer.
Liang ZM; Chen Y; Luo ML
Adv Exp Med Biol; 2017; 1026():147-169. PubMed ID: 29282683
[TBL] [Abstract][Full Text] [Related]
38. [Together, towards precise oncology!].
Coukos G; Michielin O; Dietrich P; Aapro M
Rev Med Suisse; 2014 May; 10(431):1099-100. PubMed ID: 24941676
[No Abstract] [Full Text] [Related]
39. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
Liu Y; Solomon M; Achilefu S
Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
[TBL] [Abstract][Full Text] [Related]
40. Challenges and future of precision medicine strategies for breast cancer based on a database on drug reactions.
Zhang X; Yang H; Zhang R
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31387972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
